uveal melanoma
Showing 1 - 25 of 2,548
Psychoeducation for Uveal Melanoma
Not yet recruiting
- Uveal Melanoma
- Education for Intervention
- Best Practice
- (no location specified)
Oct 4, 2023
Phase of Uveal Melanoma: A Prospective Multi-method Study
Not yet recruiting
- Uveal Melanoma
- Questionnaires and interviews
- (no location specified)
Oct 4, 2023
Metastatic Uveal Melanoma Trial in Tampa (ZIV-Aflibercept, Cemiplimab)
Recruiting
- Metastatic Uveal Melanoma
-
Tampa, FloridaMoffitt Cancer Center
Nov 2, 2023
Uveal Melanoma Trial in Pittsburgh (Tebentafusp)
Not yet recruiting
- Uveal Melanoma
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Oct 5, 2023
Uveal Melanoma Trial in Vienna (any therapy suitable)
Recruiting
- Uveal Melanoma
- any therapy suitable
-
Vienna, AustriaMedical University of Vienna
Feb 8, 2023
Morphological, Genetic and Tumour Microenvironment
Recruiting
- Uveal Melanoma
- cytogenetic analysis on tumour tissue
- Digital Pathology
-
Rome, ItalyMonica Maria Pagliara - Oncologia Oculare
May 26, 2023
Metastatic Uveal Melanoma Trial in Grand Rapids (IDE196, Crizotinib, Pembrolizumab)
Recruiting
- Metastatic Uveal Melanoma
- IDE196
- +5 more
-
Grand Rapids, MichiganThe Cancer and Hematology Centers
Aug 14, 2023
Advanced Uveal Melanoma, Metastatic Uveal Melanoma, Unresectable Uveal Melanoma Trial (BRD4 Inhibitor PLX2853, Trametinib,
Not yet recruiting
- Advanced Uveal Melanoma
- +2 more
- BRD4 Inhibitor PLX2853
- +4 more
- (no location specified)
Jan 9, 2023
Uveal Melanoma Trial in Nice, Paris (Supportive care visit with questionnaires, Oncological standard visit)
Recruiting
- Uveal Melanoma
- Supportive care visit with questionnaires
- Oncological standard visit
-
Nice, France
- +1 more
Jan 19, 2023
Uveal Melanoma, Melanoma, Metastatic Uveal Melanoma Trial in Harrison, New York (Lifileucel (LN-144))
Recruiting
- Uveal Melanoma
- +3 more
- Lifileucel (LN-144)
-
Harrison, New York
- +1 more
Nov 8, 2022
Stage IV Uveal Melanoma Trial in Philadelphia (Sir-Spheres®)
Active, not recruiting
- Stage IV Uveal Melanoma
- Sir-Spheres®
-
Philadelphia, PennsylvaniaThomas Jefferson University
Dec 20, 2022
Uveal Melanoma Trial in San Francisco (stereotactic body radiotherapy, Immunotherapy)
Recruiting
- Uveal Melanoma
- stereotactic body radiotherapy
- Immunotherapy
-
San Francisco, CaliforniaCalifornia Pacific Medical Center Research Institute
Dec 2, 2022
Uveal Melanoma, Uveal Melanoma, Posterior, Medium/Large Size, Eye Cancer, Intraocular Melanoma Trial in Stockholm (Melatonin)
Not yet recruiting
- Uveal Melanoma
- +2 more
-
Stockholm, SwedenSt. Erik Eye Hospital
Aug 14, 2022
Uveal Melanoma Trial in Minneapolis (PAC-1, Entrectinib)
Active, not recruiting
- Uveal Melanoma
-
Minneapolis, MinnesotaHealthPartners Institute Regions Cancer Care Center
Nov 15, 2022
Metastatic Uveal Melanoma Trial in Miami (Nivolumab, Relatlimab)
Recruiting
- Metastatic Uveal Melanoma
-
Miami, FloridaUniversity of Miami Sylvester Comprehensive Cancer Center
Aug 23, 2022
Melanoma, Uveal Tumors Trial in Gothenburg (IHP)
Active, not recruiting
- Melanoma
- Uveal Neoplasms
- IHP
-
Gothenburg, SwedenSahlgrenska University Hospital
Oct 26, 2022
Metastatic Uveal Melanoma Trial in Philadelphia (Defactinib Hydrochloride, Raf/MEK Inhibitor VS-6766)
Recruiting
- Metastatic Uveal Melanoma
- Defactinib Hydrochloride
- +2 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jan 23, 2023
Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7 Trial in Philadelphia
Active, not recruiting
- Metastatic Malignant Neoplasm in the Liver
- +2 more
- Ipilimumab
- +2 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Aug 15, 2022
Uveal Melanoma Trial in Grand Rapids (Darovasertib)
Recruiting
- Uveal Melanoma
-
Grand Rapids, MichiganThe Cancer and Hematology Centers
Jun 14, 2023
Uveal Tumors, Melanoma, Uveal Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL))
Recruiting
- Uveal Neoplasms
- Melanoma, Uveal
- Tumor Infiltrating Lymphocytes (TIL)
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jul 21, 2022
Metastatic Uveal Melanoma Trial in Tampa (Binimetinib, Belinostat)
Recruiting
- Metastatic Uveal Melanoma
-
Tampa, FloridaMoffitt Cancer Center
Jun 21, 2022
Metastatic Uveal Melanoma Trial in Paris (Pembrolizumab 25 MG/1 ML Intravenous Solution)
Recruiting
- Metastatic Uveal Melanoma
- Pembrolizumab 25 MG/1 ML Intravenous Solution
-
Paris, FranceInstitut Curie
Aug 3, 2022
Melanoma, Uveal Trial in Portland (Pembrolizumab, Lenvatinib)
Recruiting
- Melanoma, Uveal
-
Portland, OregonProvidence Portland Medical Center
Aug 2, 2022